Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P1.03-045 - HER-2 Mutation Is Not a Prognostic Factor Treated with First-Line Chemotherapy in NSCLC Patients
09:30 - 09:30 | Presenter: Tao Jiang | Author(s): C. Zhao, X. Li, C. Su, X. Chen, Shengxiang Ren, Caicun Zhou
- Abstract
Loading... -
+
P1.03-052 - Comparing EGFR-TKI with EGFR-TKI plus Chemotherapy as 1st Line Treatment in Advanced NSCLC Patients with Both Mutated EGFR and Bim Polymorphism
09:30 - 09:30 | Presenter: Yayi He | Author(s): C. Zhao, X. Li, Shengxiang Ren, Tao Jiang, J. Zhang, C. Su, X. Chen, Weijing Cai, G. Gao, W. Li, Fengying Wu, J. Li, J. Zhao, Fei Zhou, Q. Hu, Fred R. Hirsch, Caicun Zhou
- Abstract
Loading...
-
+
P1.04 - Clinical Design, Statistics and Clinical Trials
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Clinical Design, Statistics and Clinical Trials
-
+
P1.04-008 - POSEIDON: A Phase 3 Study of First-Line Durvalumab ± Tremelimumab + Chemotherapy vs Chemotherapy Alone in Metastatic NSCLC
09:30 - 09:30 | Presenter: Tony SK Mok | Author(s): M.L. Johnson, Edward Brian Garon, Solange Peters, J. Soria, L. Wang, A. Jarkowski, P.A. Dennis, Caicun Zhou
- Abstract
Loading...
-
+
P1.15 - SCLC/Neuroendocrine Tumors
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: SCLC/Neuroendocrine Tumors
-
+
P1.15-009 - Safety and Efficacy of Nab-Paclitaxel Monotherapy as 2nd or Later Line Setting in Pts with Extensive SCLC, a Phase II Single Arm Study (NCT02262897)
09:30 - 09:30 | Presenter: Shengxiang Ren | Author(s): G. Gao, W. Li, X. Chen, Fengying Wu, C. Su, J. Zhao, Y. Sun, Weijing Cai, Caicun Zhou
- Abstract
Loading...
-
+
MA 06 - Lung Cancer Biology I
- 15:45 - 17:30
- 10/16/2017
- Location: Room 501
- Type: Mini Oral
- Track: Biology/Pathology
- Moderators:N. Motoi, Keith M Kerr
-
+
MA 06.11 - Distinct Mutational Landscape and Evolutionary Trajectories of Brain Metastasis and Liver Metastasis in Lung Adenocarcinoma
16:55 - 17:00 | Presenter: Tao Jiang | Author(s): B. Du, Caicun Zhou
- Abstract
Loading...
-
+
P2.04 - Clinical Design, Statistics and Clinical Trials
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Clinical Design, Statistics and Clinical Trials
-
+
P2.04-004 - IMpower010: A Phase III Study of Atezolizumab vs Best Supportive Care Following Adjuvant Chemotherapy in Completely Resected NSCLC
09:30 - 09:30 | Presenter: Enriqueta Felip | Author(s): Heather A Wakelee, Eric Vallieres, Caicun Zhou, Y. Zuo, F. Xia, A. Sandler, Nasser Altorki
- Abstract
Loading...
-
+
P2.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P2.07-010 - Impact of Clinicopathological Features on the Efficacy of PD-1/PD-L1 Inhibitors in Patients with Previously Treated Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Tao Jiang | Author(s): M. Qiao, Caicun Zhou
- Abstract
Loading... -
+
P2.07-047 - Poor Performance Status and BRAF Mutation Predict Grade 3-5 Immune-Related Adverse Events in Pts with Advanced NSCLC
09:30 - 09:30 | Presenter: Yan Wang | Author(s): Jinpeng Shi, W. Li, G. Gao, Shengxiang Ren, Caicun Zhou
- Abstract
Loading...
-
+
MA 11 - Emerging Diagnostic/Biomarkers in NSCLC
- 11:00 - 12:30
- 10/17/2017
- Location: Room 313 + 314
- Type: Mini Oral
- Track: Advanced NSCLC
- Moderators:M.I. Abdul Wahid, Martin Reck
-
+
MA 11.03 - Gefitinib as First-Line Treatment of Plasma CtDNA EGFR Mutation-Positive NSCLC Detected by DdPCR: BENEFIT Study (CTONG1405)
11:10 - 11:15 | Presenter: Jie Wang | Author(s): Ying Cheng, Yi-Long Wu, T. An, H. Gao, K. Wang, Qing Zhou, Y. Hu, Yong Song, C. Ding, F. Peng, L. Liang, Y. Hu, C. Huang, Caicun Zhou, Y. Shi, Li Zhang, X. Ye, Y. Sun
- Abstract
Loading... -
+
MA 11.07 - Exosomes-Transmitted MicroRNAs Promote EGFR-TKIs Resistance in NSCLC by Activating PI3K/AKT Signaling Pathway
11:40 - 11:45 | Presenter: Xiaozhen Liu | Author(s): Tao Jiang, X. Li, J. Li, L. Zhang, S. Zhao, Y. Jia, Jinpeng Shi, C. Zhao, M. Qiao, Fei Zhou, J. Zhao, Caicun Zhou
- Abstract
Loading...
-
+
OA 09 - EGFR TKI Resistance
- 11:00 - 12:30
- 10/17/2017
- Location: Room 301 + 302
- Type: Oral
- Track: Advanced NSCLC
- Moderators:Thanyanan Reungwetwattana, Lecia V Sequist
-
+
OA 09.06 - A Phase Ib Trial of Savolitinib plus Gefitinib for Chinese Patients with EGFR-Mutant MET-Amplified Advanced NSCLC
11:55 - 12:05 | Presenter: Jin -Ji Yang | Author(s): Jian Fang, Y. Shu, J. Chang, G. Chen, J. He, W. Li, X. Liu, N. Yang, Caicun Zhou, J. Huang, L. Yang, A.A. Handzel, M.M. Frigault, G. Ahmed, C. Egile, S. Morgan, Yi-Long Wu
- Abstract
Loading...
-
+
P3.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P3.01-024 - Characterization of PD-L1 Expression and Its Predictive and Prognostic Significance in EGFR-Mutant NSCLC Patients Treated with EGFR-TKIs
09:30 - 09:30 | Presenter: Tao Jiang | Author(s): Caicun Zhou
- Abstract
Loading... -
+
P3.01-026 - Analysis of Long-Term Response to First-Line Afatinib in the LUX-Lung 3, 6 and 7 Trials in Advanced EGFRm+ NSCLC
09:30 - 09:30 | Presenter: Martin Schuler | Author(s): James Chih-Hsin Yang, Lecia V Sequist, Yi-Long Wu, Caicun Zhou, S.L. Geater, Tony SK Mok, E. Tan, C. Hu, Nobuyuki Yamamoto, J. Feng, Kenneth Obyrne, Shun Lu, Vera Hirsh, Y. Huang, S. Ellis, C. Samuelsen, A. Märten, J. Fan, Keunchil Park, Luis Paz-Ares
- Abstract
Loading... -
+
P3.01-036 - A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: An Interim Analysis
09:30 - 09:30 | Presenter: Yi-Long Wu | Author(s): H. Tu, J. Feng, M. Shi, J. Zhao, Y. Wang, J. Chang, J. Wang, Ying Cheng, J. Zhu, E. Tan, K. Li, Y. Zhang, V. Lee, C. Yang, W. Su, C.L. Lam, B. Srinivasa, S. Rajappa, C. Ho, K.C. Lam, Y. Hu, S.A. Bondarde, X. Liu, J. Fan, D. Kuo, Y. Wang, K. Pang, Caicun Zhou
- Abstract
Loading... -
+
P3.01-044 - Erlotinib vs Chemotherapy in EGFR Mut+ NSCLC: OS in Three Phase III Trials Adjusting for Post-Progression Treatment Crossover
09:30 - 09:30 | Presenter: Yi-Long Wu | Author(s): Caicun Zhou, M. Truman, A. Feyereislova, R. Rossell
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.01-075 - Afatinib Dose Adjustment: Effect on Safety, Efficacy and Patient-Reported Outcomes in the LUX-Lung 3/6 Trials in EGFRm+ NSCLC
09:30 - 09:30 | Presenter: Vera Hirsh | Author(s): E. Tan, Yi-Long Wu, Lecia V Sequist, Caicun Zhou, Martin Schuler, S.L. Geater, Tony SK Mok, C. Hu, Nobuyuki Yamamoto, J. Feng, Kenneth Obyrne, Shun Lu, Y. Huang, M. Sebastian, Isamu Okamoto, N. Dickgreber, R. Shah, M. Palmer, A. Märten, D. Massey, C. Samuelsen, James Chih-Hsin Yang
- Abstract
Loading... -
+
P3.01-085 - A Phase 2 Trial of Apatinib in Advanced Non-Squamous NSCLC: Updated Data and Clinical Benefit of Continuing Apatinib after Initial Progression
09:30 - 09:30 | Presenter: Fengying Wu | Author(s): S. Zhang, J. Yu, G. Gao, W. Li, Weijing Cai, C. Su, X. Chen, S. Ren, Caicun Zhou
- Abstract
Loading...
-
+
P3.15 - SCLC/Neuroendocrine Tumors
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: SCLC/Neuroendocrine Tumors